{"id":"https://openalex.org/W2567036611","doi":"https://doi.org/10.1002/prp2.281","title":"Absorption, distribution, metabolism, and excretion of [14 C]-dasotraline in humans","display_name":"Absorption, distribution, metabolism, and excretion of [14 C]-dasotraline in humans","publication_year":2016,"publication_date":"2016-12-18","ids":{"openalex":"https://openalex.org/W2567036611","doi":"https://doi.org/10.1002/prp2.281","mag":"2567036611","pmid":"https://pubmed.ncbi.nlm.nih.gov/28596833","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5461651"},"language":"en","primary_location":{"id":"doi:10.1002/prp2.281","doi":"https://doi.org/10.1002/prp2.281","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.281","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.281","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.281","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013512751","display_name":"Yu\u2010Luan Chen","orcid":"https://orcid.org/0000-0002-2866-3602","observed_orcids":["https://orcid.org/0000-0002-2866-3602"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yu-Luan Chen","raw_affiliation_strings":["Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086203488","display_name":"Estela Skende","orcid":"https://orcid.org/0009-0005-3977-1616","observed_orcids":["https://orcid.org/0009-0005-3977-1616"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Estela Skende","raw_affiliation_strings":["Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018717322","display_name":"Lin Jing","orcid":"https://orcid.org/0000-0002-3908-952X","observed_orcids":["https://orcid.org/0000-0002-3908-952X"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Lin","raw_affiliation_strings":["Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056200404","display_name":"Yijun Yi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yijun Yi","raw_affiliation_strings":["XenoBiotic Laboratories, Inc., Plainsboro, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"XenoBiotic Laboratories, Inc., Plainsboro, New Jersey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091759963","display_name":"Peter L. Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter L. Wang","raw_affiliation_strings":["XenoBiotic Laboratories, Inc., Plainsboro, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"XenoBiotic Laboratories, Inc., Plainsboro, New Jersey","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sarah Wills","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60638368","display_name":"Covance (United States)","ror":"https://ror.org/02hhsqf45","country_code":"US","type":"company","lineage":["https://openalex.org/I60638368"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Wills","raw_affiliation_strings":["Covance Laboratories, Inc., Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance Laboratories, Inc., Madison, Wisconsin","institution_ids":["https://openalex.org/I60638368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006590215","display_name":"H. Scott Wilkinson","orcid":"https://orcid.org/0009-0001-6949-7380","observed_orcids":["https://orcid.org/0009-0001-6949-7380"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Scott Wilkinson","raw_affiliation_strings":["Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084126298","display_name":"Kenneth S. Koblan","orcid":"https://orcid.org/0000-0001-6103-2629","observed_orcids":["https://orcid.org/0000-0001-6103-2629"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth S. Koblan","raw_affiliation_strings":["Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063897129","display_name":"Seth C. Hopkins","orcid":"https://orcid.org/0000-0003-3999-2281","observed_orcids":["https://orcid.org/0000-0003-3999-2281"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seth C. Hopkins","raw_affiliation_strings":["Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts","institution_ids":["https://openalex.org/I4210122020"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013512751"],"corresponding_institution_ids":["https://openalex.org/I4210122020"],"apc_list":{"value":4160,"currency":"USD","value_usd":4160},"apc_paid":{"value":4160,"currency":"USD","value_usd":4160},"fwci":0.6749,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.62666525,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"5","issue":"1","first_page":"e00281","last_page":"e00281"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8920000195503235},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.8700000047683716},{"id":"https://openalex.org/keywords/sulfation","display_name":"sulfation","score":0.5860000252723694},{"id":"https://openalex.org/keywords/glucuronidation","display_name":"glucuronidation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/n-hydroxylation","display_name":"N-hydroxylation","score":0.8870000243186951},{"id":"https://openalex.org/keywords/n-acetylation","display_name":"N-acetylation","score":0.8560000061988831},{"id":"https://openalex.org/keywords/oxidative-deamination","display_name":"oxidative deamination","score":0.7860000133514404},{"id":"https://openalex.org/keywords/tetralone","display_name":"tetralone","score":0.6710000038146973},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.6179999709129333},{"id":"https://openalex.org/keywords/fecal-excretion","display_name":"fecal excretion","score":0.9340000152587891},{"id":"https://openalex.org/keywords/metabolite-identification","display_name":"metabolite identification","score":0.5580000281333923},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.531000018119812},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8169604539871216},{"id":"https://openalex.org/C2779907587","wikidata":"https://www.wikidata.org/wiki/Q14901439","display_name":"Glucuronidation","level":4,"score":0.7831897139549255},{"id":"https://openalex.org/C2779186261","wikidata":"https://www.wikidata.org/wiki/Q137786","display_name":"Glucuronide","level":3,"score":0.5643662810325623},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.5635294914245605},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5369278192520142},{"id":"https://openalex.org/C197974221","wikidata":"https://www.wikidata.org/wiki/Q2526373","display_name":"Oxidative deamination","level":3,"score":0.45351049304008484},{"id":"https://openalex.org/C10146269","wikidata":"https://www.wikidata.org/wiki/Q185557","display_name":"Excretion","level":2,"score":0.43646958470344543},{"id":"https://openalex.org/C2776730177","wikidata":"https://www.wikidata.org/wiki/Q421721","display_name":"Acetamide","level":2,"score":0.4315020740032196},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.36027562618255615},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21193912625312805},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0824446976184845},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07615220546722412},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1002/prp2.281","doi":"https://doi.org/10.1002/prp2.281","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.281","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.281","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4314007","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5461651","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:28596833","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28596833","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology research & perspectives","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5461651","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5461651/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacol Res Perspect","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/prp2.281","doi":"https://doi.org/10.1002/prp2.281","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.281","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.281","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311407","display_name":"Sunovion","ror":"https://ror.org/030zc7t66"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2567036611.pdf","grobid_xml":"https://content.openalex.org/works/W2567036611.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1509358020","https://openalex.org/W1530247857","https://openalex.org/W1767927283","https://openalex.org/W1966928541","https://openalex.org/W1976172596","https://openalex.org/W1988733714","https://openalex.org/W1990938178","https://openalex.org/W2049651681","https://openalex.org/W2050106873","https://openalex.org/W2069969143","https://openalex.org/W2095404929","https://openalex.org/W2104980068","https://openalex.org/W2133849435","https://openalex.org/W2149528043","https://openalex.org/W2172658446","https://openalex.org/W2794522676","https://openalex.org/W4291181444"],"related_works":["https://openalex.org/W2118915101","https://openalex.org/W2043684694","https://openalex.org/W2091137497","https://openalex.org/W2146413877","https://openalex.org/W3146922707","https://openalex.org/W2130574441","https://openalex.org/W2033602954","https://openalex.org/W2084040204","https://openalex.org/W4229024074","https://openalex.org/W1518881239"],"abstract_inverted_index":{"Dasotraline":[0],"is":[1],"a":[2,14,33,214,264],"dopamine":[3],"and":[4,8,17,27,60,76,89,105,111,113,127,137,148,150,156,167,179,204,234,239],"norepinephrine":[5],"reuptake":[6],"inhibitor,":[7],"the":[9,23,51,57,172,182,200],"early":[10,209],"clinical":[11],"trials":[12],"show":[13],"slow":[15],"absorption":[16],"long":[18],"elimination":[19],"half-life.":[20],"To":[21],"investigate":[22],"absorption,":[24],"distribution,":[25],"metabolism,":[26],"excretion":[28],"of":[29,36,50,103,122,171,174,181,199,253],"dasotraline":[30,188,230,254],"in":[31,56,132,140,152],"humans,":[32],"single":[34],"dose":[35],"[14C]-dasotraline":[37],"was":[38,54,205,213,231],"administered":[39],"to":[40,72,79,84,92,98,108,116],"eight":[41],"healthy":[42],"male":[43],"adult":[44],"volunteers.":[45],"At":[46],"35":[47],"days,":[48],"90.7%":[49],"dosed":[52],"radioactivity":[53,203,220],"recovered":[55],"urine":[58,141],"(68.3%)":[59],"feces":[61,153],"(22.4%).":[62],"The":[63,158,192,226,244],"major":[64],"metabolic":[65],"pathways":[66],"involved":[67],"were:":[68],"(1)":[69],"amine":[70],"oxidation":[71,238],"form":[73,80,85,93,99,109,117],"oxime":[74,173,193],"M41":[75,194],"sequential":[77,90,106],"sulfation":[78],"M42":[81],"or":[82],"glucuronidation":[83,91,107],"M43;":[86],"(2)":[87],"N-hydroxylation":[88],"M35;":[94],"(3)":[95],"oxidative":[96],"deamination":[97],"(S)-tetralone;":[100],"(4)":[101],"mono-oxidation":[102],"(S)-tetralone":[104],"M31A":[110],"M32;":[112],"(5)":[114],"N-acetylation":[115],"(1R,4S)-acetamide":[118],"M102.":[119],"A":[120],"total":[121,183,201],"8":[123],"metabolites":[124,163,260],"were":[125,164],"detected":[126,206],"structurally":[128],"elucidated":[129],"with":[130],"4":[131],"plasma":[133,184,202],"(M41,":[134,142,154],"M42,":[135,143],"M43,":[136,144],"M35),":[138],"7":[139],"M31A,":[145],"M32,":[146],"M35,":[147],"(S)-tetralone),":[149],"3":[151],"(S)-tetralone,":[155],"(1R,4S)-acetamide).":[157],"2":[159],"most":[160],"abundant":[161],"circulating":[162],"sulfate":[165],"(M42)":[166],"glucuronide":[168,216],"(M43)":[169],"conjugates":[170],"dasotraline,":[175],"accounting":[176],"for":[177,190,196],"60.1%":[178],"15.0%":[180],"radioactivity,":[185],"respectively;":[186],"unchanged":[187],"accounted":[189,195],"8.59%.":[191],"only":[197,207],"0.62%":[198],"at":[208],"time":[210],"points.":[211],"M35":[212],"minor":[215],"metabolite,":[217],"undetectable":[218],"by":[219,223,237,255],"but":[221],"identified":[222],"mass":[224],"spectrometry.":[225],"results":[227],"demonstrate":[228],"that":[229,251,261],"slowly":[232],"absorbed,":[233],"extensively":[235],"metabolized":[236],"subsequent":[240],"phase":[241],"II":[242],"conjugations.":[243],"findings":[245],"from":[246],"this":[247],"study":[248],"also":[249],"demonstrated":[250],"metabolism":[252],"humans":[256],"did":[257],"not":[258],"produce":[259],"may":[262],"cause":[263],"safety":[265],"concern.":[266]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-01-06T00:00:00"}